Incorporation of conformationally constrained phenylalanine derivatives TIC, SIC, HIC and NIC into a cholecystokinin-B/gastrin receptor antagonist

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 10, 1997, Pages 1289-1292

  Gibson, Susan E ^a   Guillo, Nathalie ^a   Kalindjian, S Barret ^b   Tozer, Matthew J ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b James Black Foundation   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; PHENYLALANINE DERIVATIVE; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; STOMACH;

EID: 0031579945     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00211-4     Document Type: Article

References (20)

1. See, for example, (a) Toniolo, C. Int. J. Peptide. Protein Res. 1990, 35, 287;
2. (b) Giannis, A.; Kolter, T.; Angew. Chem., Int. Ed. Engl. 1993, 32, 1244;
3. (c) Qian, X.; Shenderovich, M.D.; Kover, K.E.; Davis, P.; Horvath, R.; Zalewska, T.; Yamamura, H.I.; Porreca, F.; Hruby, V.J. J. Am. Chem. Soc. 1996, 118, 7280.
4. Chung J.Y.L., Wasicak J.T., Arnold W.A., May C.S., Nadzan A.M., Holladay M.W. J. Org. Chem. 55:1990;270.
5. Hsieh K., LaHann T.R., Speth R.C. J. Med. Chem. 32:1989;898.
6. Kazmierski W.M., Urbanczyk-Likowska Z., Hruby V.J. J. Org. Chem. 59:1994;1789.
7. Azizeh B.Y., Shenderovich M.D., Trivedi D., Li G., Sturm N.S., Hruby V.J. J. Med. Chem. 39:1996;2449.
8. See, for example, (a) Kazmierski, W.M.; Yamamura, H.I.; Hruby, V.J. J. Am. Chem. Soc. 1991, 113, 2275;
9. (b) Schiller, P.W.; Weltrowska, G.; Nguyen, T.M.D.; Lemieux, C.; Chung, N.N.; Marsden, B.J.; Wilkes, B.C. J. Med Chem. 1991, 34, 3125;
10. (c) Kyle, D.J.; Martin, J.A.; Burch, R.M.; Carter, J.P.; Lu, S.; Meeker, S.; Prosser, J.C.; Sullivan, J.P.; Togo, J.; Noronha-Blob, L.; Sinsko, J.A.; Walters, R.F.; Whaley, L.W.; Hiner, R.N. J. Med. Chem. 1991, 34, 2649;
11. (d) Feltou, M.; Robineau, P.; Lonchampt, M.; Bonnardel, E.; Thurieau, C.; Fauchere, J.L.; Widdowson, P.; Mahieu, J.P.; Serkiz, B.; Volland, J.P.; Martin, C.; Naline, E.; Advenier, C.; Prost, J.F.; Canet, E. J. Pharm. Expt. Therap. 1995, 23, 1071;
12. (e) Wilkes, B.C.; Schiller, P.W. Biopolymers 1995, 37, 391;
13. (f) Capasso, A.; Guerrini, R.; Balboni, G.; Sorrentino, L.; Temussi, P.; Lazarus, L.H.; Bryant, S.D.; Salvadori, S. Life Sciences 1996, 59, PL 93.
14. Wang C., Mosberg H.I. Tetrahedron Lett. 36:1995;3623.
15. Gibson (née Thomas), S.E.; Guillo, N.; Middleton, R.J.; Thuilliez, A.; Tozer, M.J. J. Chem. Soc., Perkin Trans. 1 1997, 447.
16. Kalindjian S.B., Buck I.M., Davies J.M.R., Dunstone D.J., Hudson M.L., Low C.M.R., McDonald I.M., Pether M.J., Steel K.I.M., Tozer M.J., Vinter J.G. J. Med. Chem. 39:1996;1806.
17. Roberts S.P., Harper E.A., Watt G.F., Gerskowitch V.P., Hull R.A.D., Shankley N.P., Black J.W. Br. J. Pharmacol. 118:1996;1779.
18. Harper E.A., Roberts S.P., Shankley N.P., Black J.W. Br. J. Pharmacol. 118:1996;1717.
19. Bock M.G., DiPardo R.M., Evans B.E., Rittle K.E., Whitter W.L., Garsky V.M., Gilbert K.F., Leighton J.L., Carson K.L., Mellin E.C., Veber D.F., Chang R.S.L., Lotti V.J., Freedman S.B., Smith A.J., Patel S., Anderson P.S., Freidinger R.M. J. Med. Chem. 36:1993;4276.
20. Hills D.M., Gerskowitch V.P., Roberts S.P., Welsh N.J., Shankley N.P., Black J.W. Br. J. Pharmacol. 119:1996;1401.